← Leaderboards
Subramanian Dhandayuthapani
Texas Tech University Health Sciences Center At El Paso
$2,767,116
Attributed
$2,767,116
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $596.3K · FY2010–25$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,767,116 · 4
By mechanism
R01$1,373,187 · 1
R21$767,727 · 2
R15$626,202 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Immunogenic”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$489,963,650
- Lawrence Corey · Fred Hutchinson Cancer Center$378,262,806
- Barton F Haynes · Duke University$364,422,244
- Dennis R. Burton · Scripps Research Institute$311,593,259
- Peter B. Gilbert · Fred Hutchinson Cancer Center$200,471,907
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$172,054,560
Research focus
ImmunogenicAdultDendritic CellsMacrophageVaccinesCellsImmune ResponseMycobacterium TuberculosisPulmonary TuberculosisDoseTuberculosisAttenuatedGenesTissuesVirulentBcg VaccineProteinsOverexpressionInfectionRecombinantsPhagosomesGenerationsAttenuated VaccinesCessation Of Life
Grant awards (10)
A novel hyper-immunogenic low virulent BCG vaccine against tuberculosis$458,789
R01 · FY2025 · AI · contact PI
A novel hyper-immunogenic low virulent BCG vaccine against tuberculosis$452,019
R01 · FY2024 · AI · contact PI
A novel hyper-immunogenic low virulent BCG vaccine against tuberculosis$462,379
R01 · FY2023 · AI · contact PI
A novel quadruple knockout MTb vaccine against tuberculosis (Supplement Resubmission)$133,944
R15 · FY2023 · AI · contact PI
A novel Quadruple Knockout Mtb vaccine against tuberculosis$492,258
R15 · FY2021 · AI · contact PI
Novel Bacillus subtilis based spore vaccine to tuberculosis$128,169
R21 · FY2013 · AI · contact PI
Novel Bacillus subtilis based spore vaccine to tuberculosis$58,706
R21 · FY2013 · AI · contact PI
Novel Bacillus subtilis based spore vaccine to tuberculosis$186,458
R21 · FY2012 · AI · contact PI
Promotion of HIV-1 transinfection by Mycoplasma genitalium$183,769
R21 · FY2011 · AI · contact PI
Promotion of HIV-1 transinfection by Mycoplasma genitalium$210,625
R21 · FY2010 · AI · contact PI